Weigao Blood Purification 2025 6.36 million restricted stock incentive plan grant results announced

Shandong Weigao Blood Purification Products Co., Ltd. announced the results of the 2025 restricted stock incentive plan grant. On September 16, it was determined to grant 6.36 million shares of restricted stock to 120 incentive recipients, with a grant price of 19.77 yuan per share, and the stock source is from a targeted issuance of A-share common stock. The maximum validity period is no more than 48 months, and the lock-up period starts from the date of registration, with a gap of no less than 12 months between the grant and the first release of the lock-up. Registration was completed on September 29, raising 125.7 million yuan for liquidity support. In terms of equity structure, the restricted shares increased by 6.36 million shares. The cost of this plan will be expensed, and although it will impact net profit in each year, it is expected to stimulate employee motivation and enhance long-term performance